COLEC10

gene
On this page

Also known as CL-L1CL-10

Summary

COLEC10 (collectin subfamily member 10, HGNC:2220) is a protein-coding gene on chromosome 8q24.12, encoding Collectin-10 (Q9Y6Z7). Lectin that binds to various sugars: galactose > mannose = fucose > N-acetylglucosamine > N-acetylgalactosamine.

This gene encodes a member of the C-lectin family, proteins that possess collagen-like sequences and carbohydrate recognition domains. The other members of this family are secreted proteins and bind to carbohydrate antigens on microorganisms facilitating their recognition and removal. This gene product is a cytosolic protein, a characteristic that suggests that it may have different biological functions than other C-lectins.

Source: NCBI Gene 10584 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): 3MC syndrome 3 (Strong, GenCC) — +1 more curated relationship
  • GWAS associations: 17
  • Clinical variants (ClinVar): 63 total — 4 pathogenic, 2 likely-pathogenic
  • Phenotypes (HPO): 48
  • MANE Select transcript: NM_006438

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:2220
Approved symbolCOLEC10
Namecollectin subfamily member 10
Location8q24.12
Locus typegene with protein product
StatusApproved
AliasesCL-L1, CL-10
Ensembl geneENSG00000184374
Ensembl biotypeprotein_coding
OMIM607620
Entrez10584

Gene structure

Transcript identifiers

Ensembl transcripts: 7 — 6 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000332843, ENST00000521788, ENST00000892374, ENST00000892375, ENST00000892376, ENST00000892377, ENST00000892378

RefSeq mRNA: 2 — MANE Select: NM_006438 NM_001324095, NM_006438

CCDS: CCDS6327

Canonical transcript exons

ENST00000332843 — 6 exons

ExonStartEnd
ENSE00001304898119105800119108455
ENSE00001309494119067247119067429
ENSE00001325106119103800119103895
ENSE00003497438119089680119089751
ENSE00003540400119102348119102401
ENSE00003671329119091149119091220

Expression profiles

Bgee: expression breadth broad, 91 present calls, max score 85.41.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.5356 / max 127.6159, expressed in 85 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
903720.276348
903710.138834
903700.068725
903690.051716

Top tissues by expression

259 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right lobe of liverUBERON:000111485.41gold quality
liverUBERON:000210778.89gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047377.63gold quality
stromal cell of endometriumCL:000225573.97gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099172.53gold quality
right lungUBERON:000216762.51gold quality
gall bladderUBERON:000211058.46gold quality
heart left ventricleUBERON:000208458.16gold quality
cardiac ventricleUBERON:000208257.57gold quality
adrenal tissueUBERON:001830357.45gold quality
pancreatic ductal cellCL:000207957.01silver quality
islet of LangerhansUBERON:000000655.86gold quality
apex of heartUBERON:000209855.45gold quality
right coronary arteryUBERON:000162553.07gold quality
placentaUBERON:000198752.44gold quality
left lobe of thyroid glandUBERON:000112052.37gold quality
prefrontal cortexUBERON:000045151.88gold quality
heartUBERON:000094851.82gold quality
colonic epitheliumUBERON:000039751.76gold quality
metanephros cortexUBERON:001053351.61gold quality
tibial arteryUBERON:000761051.45gold quality
thyroid glandUBERON:000204651.44gold quality
lungUBERON:000204851.41gold quality
popliteal arteryUBERON:000225051.38gold quality
cortical plateUBERON:000534351.10silver quality
calcaneal tendonUBERON:000370151.06silver quality
metanephrosUBERON:000008151.02gold quality
ileal mucosaUBERON:000033150.96silver quality
epithelial cell of pancreasCL:000008350.68gold quality
upper lobe of left lungUBERON:000895250.66gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-MTAB-7407yes1021.67
E-ANND-3no4.24

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

86 targeting COLEC10, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5692A100.0074.406850
HSA-MIR-513A-5P100.0069.772465
HSA-MIR-126-5P100.0072.713180
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-4455100.0065.481587
HSA-MIR-4262100.0073.263931
HSA-MIR-7110-3P100.0073.182486
HSA-MIR-3134100.0066.43777
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-3667-3P99.9967.171636
HSA-MIR-366299.9973.825684
HSA-MIR-428299.9975.366408
HSA-MIR-477599.9875.006394
HSA-MIR-27A-3P99.9872.132955
HSA-MIR-27B-3P99.9872.132955
HSA-MIR-998599.9872.112939
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-4482-3P99.9872.503147
HSA-MIR-314899.9775.066478
HSA-MIR-590-3P99.9674.346478
HSA-MIR-146A-5P99.9668.93988
HSA-MIR-146B-5P99.9669.13977
HSA-MIR-551B-5P99.9671.283493
HSA-MIR-7153-5P99.9468.891006
HSA-MIR-139-5P99.8069.501399
HSA-MIR-148A-3P99.7473.771700
HSA-MIR-148B-3P99.7473.751700
HSA-MIR-152-3P99.7473.751703
HSA-MIR-545-5P99.6670.182308

Literature-anchored findings (GeneRIF, showing 11)

  • Most plasma CL-K1 was found in complex with CL-L1 in a ratio suggesting a heteromeric subunit of 1 CL-L1 & 2 CL-K1 polypeptides. (PMID:24174618)
  • Carriers of COLEC10 Arg125Trp had increased CL-L1 serum levels. (PMID:25710878)
  • Data indicate differences in the plasma concentrations of collectin liver 1 and collectin kidney 1, M-ficolin and H-ficol in systemic lupus erythematosus (SLE) patients compared to a group of healthy controls. (PMID:26154564)
  • high serum CL-L1 concentration in critically ill children upon PICU admission is associated with an increased risk of infection and prolonged need of intensive care, and counteracts the protective effect of having a high MASP-3 concentration (PMID:27057739)
  • High CLL1 expression is associated with cardiovascular disease. (PMID:27341702)
  • Exome sequencing reveals mutations in collectin sub-family member 10 (C-type lectin) protein (COLEC10) as a cause of 3MC syndrome with main features include facial dysmorphism, craniosynostosis and cleft lip/palate. (PMID:28301481)
  • Collectin liver 1 (CL-L1, collectin 10) and collectin kidney 1 (CL-K1, collectin 11) were found widespread and almost identical tissue with a high expression in epithelial cells in endo-/exocrine secretory tissues and mucosa. (PMID:30108587)
  • Association of Polymorphisms of MASP1/3, COLEC10, and COLEC11 Genes with 3MC Syndrome. (PMID:32751929)
  • A novel COLEC10 mutation in a child with 3MC syndrome. (PMID:34740859)
  • COLEC10 Induces Endoplasmic Reticulum Stress by Occupying GRP78 and Inhibits Hepatocellular Carcinoma. (PMID:36925047)
  • The C-type lectin COLEC10 is predominantly produced by hepatic stellate cells and involved in the pathogenesis of liver fibrosis. (PMID:38036508)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_rerioCOLEC10ENSDARG00000104752
mus_musculusColec10ENSMUSG00000038591
rattus_norvegicusColec10ENSRNOG00000008591

Paralogs (4): COLEC11 (ENSG00000118004), SFTPA1 (ENSG00000122852), SFTPD (ENSG00000133661), SFTPA2 (ENSG00000185303)

Protein

Protein identifiers

Collectin-10Q9Y6Z7 (reviewed: Q9Y6Z7)

Alternative names: Collectin liver protein 1, Collectin-34

All UniProt accessions (1): Q9Y6Z7

UniProt curated annotations — full annotation on UniProt →

Function. Lectin that binds to various sugars: galactose > mannose = fucose > N-acetylglucosamine > N-acetylgalactosamine. Acts as a chemoattractant, probably involved in the regulation of cell migration.

Subcellular location. Secreted. Golgi apparatus. Cytoplasm.

Tissue specificity. Highly expressed in liver, placenta and adrenal gland. Moderately expressed in small intestine, lung, stomach and prostate. Weakly expressed in trachea and spleen.

Disease relevance. 3MC syndrome 3 (3MC3) [MIM:248340] A form of 3MC syndrome, an autosomal recessive disorder characterized by facial dysmorphism, craniosynostosis, learning disability, and genital, limb and vesicorenal anomalies. Facial features include hypertelorism, blepharophimosis, blepharoptosis and highly arched eyebrows, cleft lip and/or palate. The term 3MC syndrome includes Carnevale, Mingarelli, Malpuech, and Michels syndromes. The disease is caused by variants affecting the gene represented in this entry.

Similarity. Belongs to the COLEC10/COLEC11 family.

RefSeq proteins (2): NP_001311024, NP_006429* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001304C-type_lectin-likeDomain
IPR008160CollagenRepeat
IPR016186C-type_lectin-like/link_sfHomologous_superfamily
IPR016187CTDL_foldHomologous_superfamily
IPR018378C-type_lectin_CSConserved_site
IPR033990Collectin_CTLDDomain
IPR051663CLec_Tetranectin-domainFamily

Pfam: PF00059, PF01391

UniProt features (13 total): sequence variant 2, sequence conflict 2, domain 2, disulfide bond 2, signal peptide 1, chain 1, region of interest 1, compositionally biased region 1, glycosylation site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9Y6Z7-F181.200.47

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Disulfide bonds (2): 176–270, 248–262

Glycosylation sites (1): 258

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-166662Lectin pathway of complement activation
R-HSA-166663Initial triggering of complement

MSigDB gene sets: 258 (showing top): BROWNE_HCMV_INFECTION_30MIN_DN, GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP, REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_POSITIVE_REGULATION_OF_ENDOCYTOSIS, GOCC_COLLAGEN_TRIMER, REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS, GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN, GOCC_CELL_SURFACE, GOBP_VESICLE_MEDIATED_TRANSPORT, FOXO4_01, LHX3_01, AAAYRNCTG_UNKNOWN, GOBP_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT, GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS, GOBP_TAXIS

GO Biological Process (6): complement activation, lectin pathway (GO:0001867), cell surface pattern recognition receptor signaling pathway (GO:0002752), proteolysis (GO:0006508), positive regulation of opsonization (GO:1903028), cranial skeletal system development (GO:1904888), positive chemotaxis (GO:0050918)

GO Molecular Function (4): D-mannose binding (GO:0005537), chemoattractant activity (GO:0042056), protein binding (GO:0005515), carbohydrate binding (GO:0030246)

GO Cellular Component (7): extracellular region (GO:0005576), collagen trimer (GO:0005581), obsolete extracellular space (GO:0005615), cytoplasm (GO:0005737), Golgi apparatus (GO:0005794), external side of plasma membrane (GO:0009897), serine-type endopeptidase complex (GO:1905370)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Creation of C4 and C2 activators1
Complement cascade1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding2
cellular anatomical structure2
complement activation1
innate immune response1
innate immune response activating cell surface receptor signaling pathway1
pattern recognition receptor signaling pathway1
protein metabolic process1
positive regulation of immune effector process1
opsonization1
positive regulation of phagocytosis1
regulation of opsonization1
anatomical structure development1
chemotaxis1
monosaccharide binding1
receptor ligand activity1
positive chemotaxis1
protein-containing complex1
intracellular anatomical structure1
cytoplasm1
endomembrane system1
intracellular membrane-bounded organelle1
plasma membrane1
cell surface1
side of membrane1
serine-type peptidase complex1
endopeptidase complex1

Protein interactions and networks

STRING

790 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
COLEC10FCN2Q15485883
COLEC10MASP2O00187880
COLEC10COLEC11Q9BWP8874
COLEC10FCN3O75636859
COLEC10F8W876F8W876804
COLEC10CD33P20138753
COLEC10KIR3DL1P43629704
COLEC10IL3RAP26951671
COLEC10MBL2P11226662
COLEC10CLEC12AQ5QGZ9623
COLEC10FCN1O00602578
COLEC10CD38P28907571
COLEC10CD96P40200571
COLEC10CCBE1Q6UXH8517
COLEC10CD47Q08722514

IntAct

10 interactions, top by confidence:

ABTypeScore
MASP2COLEC11psi-mi:“MI:0915”(physical association)0.520
MASP1COLEC11psi-mi:“MI:0915”(physical association)0.520
COLEC11COLEC10psi-mi:“MI:0915”(physical association)0.400
COLEC10COLEC11psi-mi:“MI:0915”(physical association)0.400
COLEC11psi-mi:“MI:0915”(physical association)0.400
COLEC10PTX3psi-mi:“MI:0914”(association)0.350
COLEC10PLOD2psi-mi:“MI:0914”(association)0.350
KRASESYT2psi-mi:“MI:2364”(proximity)0.270

BioGRID (39): NUCB2 (Affinity Capture-MS), P3H4 (Affinity Capture-MS), COLGALT2 (Affinity Capture-MS), DNAJB9 (Affinity Capture-MS), CKAP4 (Affinity Capture-MS), MIA3 (Affinity Capture-MS), ARL8A (Affinity Capture-MS), TIMP3 (Affinity Capture-MS), PTX3 (Affinity Capture-MS), STC2 (Affinity Capture-MS), INHBE (Affinity Capture-MS), MCU (Affinity Capture-MS), DCP2 (Affinity Capture-MS), COLEC10 (Co-fractionation), PTX3 (Affinity Capture-MS)

ESM2 similar proteins: B1A4N2, B1A4P2, B1A4P8, B1A4Q3, B1A4Q5, C0STK6, O02659, P06908, P08427, P08661, P11226, P12842, P19999, P23805, P35242, P35247, P35248, P39039, P41317, P42916, P49874, P50403, P50404, Q1PBC5, Q2LK95, Q5M8X6, Q5U9S1, Q66S37, Q66S41, Q66S45, Q66S50, Q66S54, Q66S58, Q66S60, Q66S61, Q66S62, Q66S63, Q66S64, Q66S65, Q6RXL1

Diamond homologs: B1A4M7, B1A4Q6, B1A4Q8, B1A4Q9, B2D1Y0, C0STK6, O02659, P06908, P08427, P08661, P11226, P12842, P19999, P20693, P21755, P23805, P35242, P35246, P35247, P35248, P39039, P42916, P49874, P50403, P50404, P82142, Q1PBC5, Q28062, Q2LK95, Q5M8X6, Q5U9S1, Q61361, Q62028, Q66S60, Q66S61, Q66S62, Q66S63, Q66S64, Q684R7, Q6RXL1

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

63 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic4
Likely pathogenic2
Uncertain significance44
Likely benign8
Benign3

Top pathogenic / likely-pathogenic (6)

Variant IDHGVSClassification
417733NM_006438.5(COLEC10):c.25C>T (p.Arg9Ter)Pathogenic
417734NM_006438.5(COLEC10):c.228del (p.Gly77fs)Pathogenic
417735NM_006438.5(COLEC10):c.528C>G (p.Cys176Trp)Pathogenic
6968nsv513786Pathogenic
4072585NM_006438.5(COLEC10):c.442+1G>ALikely pathogenic
4081283NM_006438.5(COLEC10):c.311G>T (p.Gly104Val)Likely pathogenic

SpliceAI

1257 predictions. Top by Δscore:

VariantEffectΔscore
8:119089675:A:AGacceptor_gain1.0000
8:119089676:A:Gacceptor_gain1.0000
8:119102344:TCAG:Tacceptor_loss1.0000
8:119102345:CAGG:Cacceptor_loss1.0000
8:119102346:A:AGacceptor_gain1.0000
8:119102347:G:GGacceptor_gain1.0000
8:119102398:GCAG:Gdonor_gain1.0000
8:119102399:CAGGT:Cdonor_loss1.0000
8:119102400:AGG:Adonor_loss1.0000
8:119102401:GGT:Gdonor_loss1.0000
8:119102402:G:GAdonor_loss1.0000
8:119102654:G:GTdonor_gain1.0000
8:119102692:GCA:Gdonor_gain1.0000
8:119102695:G:GGdonor_gain1.0000
8:119103891:GAATG:Gdonor_gain1.0000
8:119103896:GTGAG:Gdonor_loss1.0000
8:119103897:T:Gdonor_loss1.0000
8:119105797:CAGTG:Cacceptor_loss1.0000
8:119105798:A:AGacceptor_gain1.0000
8:119105798:AGT:Aacceptor_gain1.0000
8:119105799:G:GGacceptor_gain1.0000
8:119105799:GT:Gacceptor_gain1.0000
8:119105799:GTG:Gacceptor_gain1.0000
8:119105799:GTGA:Gacceptor_gain1.0000
8:119105799:GTGAT:Gacceptor_gain1.0000
8:119089675:AAAAG:Aacceptor_gain0.9900
8:119091219:GG:Gdonor_gain0.9900
8:119091220:GG:Gdonor_gain0.9900
8:119102333:ATT:Aacceptor_gain0.9900
8:119102335:T:Aacceptor_gain0.9900

AlphaMissense

1838 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
8:119106126:T:AW257R0.999
8:119106126:T:CW257R0.999
8:119106128:G:CW257C0.999
8:119106128:G:TW257C0.999
8:119105883:T:AC176S0.998
8:119105883:T:CC176R0.998
8:119105884:G:AC176Y0.998
8:119105884:G:CC176S0.998
8:119105885:C:GC176W0.998
8:119106059:G:CW234C0.998
8:119106059:G:TW234C0.998
8:119106165:T:AC270S0.998
8:119106166:G:CC270S0.998
8:119106165:T:CC270R0.997
8:119106166:G:AC270Y0.997
8:119105914:C:AP186H0.996
8:119106099:T:AC248S0.996
8:119106100:G:CC248S0.996
8:119106166:G:TC270F0.996
8:119106167:T:GC270W0.996
8:119105884:G:TC176F0.995
8:119106099:T:CC248R0.995
8:119106101:T:GC248W0.995
8:119106141:T:AC262S0.995
8:119106142:G:CC262S0.995
8:119105914:C:GP186R0.994
8:119106100:G:AC248Y0.994
8:119106127:G:CW257S0.994
8:119106141:T:CC262R0.994
8:119106159:T:CF268L0.994

dbSNP variants (sampled 300 via entrez): RS1000008541 (8:119022198 T>C), RS1000086917 (8:119069194 C>T), RS1000093487 (8:118964532 A>G), RS1000104467 (8:119059713 A>G), RS1000108351 (8:119092395 C>G), RS1000121109 (8:118997667 C>T), RS1000128565 (8:119004367 C>T), RS1000133886 (8:118981826 T>G), RS1000161541 (8:118980280 A>G), RS1000165842 (8:119021567 G>A), RS1000168748 (8:119045914 G>A), RS1000190353 (8:119056013 T>A), RS1000203301 (8:119056332 G>A,C), RS1000214498 (8:119082117 C>T), RS1000237750 (8:119010178 C>T)

Disease associations

OMIM: gene MIM:607620 | disease phenotypes: MIM:248340, MIM:239000

GenCC curated gene-disease

DiseaseClassificationInheritance
3MC syndrome 3StrongAutosomal recessive
3MC syndromeSupportiveAutosomal recessive

Mondo (3): 3MC syndrome 3 (MONDO:0009554), juvenile Paget disease (MONDO:0009394), 3MC syndrome (MONDO:0017398)

Orphanet (3): 3MC syndrome (Orphanet:293843), Juvenile Paget disease (Orphanet:2801), Malpuech syndrome (Orphanet:2453)

HPO phenotypes

48 total (30 of 48 shown, HPO-id order):

HPOTerm
HP:0000007Autosomal recessive inheritance
HP:0000028Cryptorchidism
HP:0000048Bifid scrotum
HP:0000054Micropenis
HP:0000085Horseshoe kidney
HP:0000175Cleft palate
HP:0000202Orofacial cleft
HP:0000204Cleft upper lip
HP:0000316Hypertelorism
HP:0000365Hearing impairment
HP:0000369Low-set ears
HP:0000377Abnormal pinna morphology
HP:0000494Downslanted palpebral fissures
HP:0000506Telecanthus
HP:0000508Ptosis
HP:0000537Epicanthus inversus
HP:0000581Blepharophimosis
HP:0000593Abnormal anterior chamber morphology
HP:0000808Penoscrotal hypospadias
HP:0000960Sacral dimple
HP:0001249Intellectual disability
HP:0001263Global developmental delay
HP:0001363Craniosynostosis
HP:0001510Growth delay
HP:0001537Umbilical hernia
HP:0001540Diastasis recti
HP:0002006Tessier cleft
HP:0002265Large fleshy ears
HP:0002553Highly arched eyebrow
HP:0002558Supernumerary nipple

GWAS associations

17 associations (top):

StudyTraitp-value
GCST002493_13Bone mineral density (paediatric, skull)2.000000e-11
GCST002493_14Bone mineral density (paediatric, skull)3.000000e-08
GCST002546_1Osteoprotegerin levels8.000000e-15
GCST002546_4Osteoprotegerin levels8.000000e-09
GCST002587_13Blood pressure (smoking interaction)2.000000e-07
GCST002587_14Blood pressure (smoking interaction)4.000000e-06
GCST005212_12Asthma5.000000e-06
GCST006979_366Heel bone mineral density4.000000e-12
GCST007800_93Asthma (childhood onset)8.000000e-11
GCST010059_10Physiological traits5.000000e-06
GCST010653_16Thyroid stimulating hormone levels4.000000e-08
GCST011353_50Serum alkaline phosphatase levels1.000000e-27
GCST90002382_251Eosinophil percentage of white cells1.000000e-09
GCST90002388_259Lymphocyte count3.000000e-10
GCST90011899_152Aspartate aminotransferase levels6.000000e-09
GCST90013407_199Liver enzyme levels (gamma-glutamyl transferase)1.000000e-19
GCST90014023_26Type 1 diabetes3.000000e-10

EFO canonical traits (10, from GWAS)

EFO IDTrait name
EFO:0006335systolic blood pressure
EFO:0006526pack-years measurement
EFO:0006525cigarettes per day measurement
EFO:0009270heel bone mineral density
EFO:0005937longitudinal BMI measurement
EFO:0004533alkaline phosphatase measurement
EFO:0007991eosinophil percentage of leukocytes
EFO:0004587lymphocyte count
EFO:0004736aspartate aminotransferase measurement
EFO:0004532serum gamma-glutamyl transferase measurement

MeSH disease descriptors (2)

DescriptorNameTree numbers
C537701Hyperostosis corticalis deformans juvenilis (supp.)
C535704Malpuech facial clefting syndrome (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

PharmGKB variants

3 variants.

VariantGenesLevelScore#Clin annotsDrugs
rs2073618COLEC10, TNFRSF11B36.251anastrozole;letrozole
rs2465403COLEC100.000
rs3134068COLEC10, TNFRSF11B0.000

CTD chemical–gene interactions

13 total (human), top 13 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Idecreases expression1
bisphenol Adecreases methylation1
sodium arseniteincreases expression1
CGP 52608affects binding, increases reaction1
Arsenic Trioxidedecreases expression1
Estradioldecreases expression1
Fluorocarbonsaffects cotreatment, increases expression1
Hydrocarbons, Chlorinatedaffects cotreatment, increases expression1
Metalsaffects cotreatment, increases expression1
Niclosamideincreases expression1
Pentachlorophenolaffects cotreatment, increases expression1
Polychlorinated Biphenylsaffects cotreatment, increases expression1
Aflatoxin B1decreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.